» Articles » PMID: 38153546

Postoperative Morbidity and Interstage Hemodynamics Following Stage I Palliation in Patients with Turner Syndrome and Hypoplastic Left Heart Syndrome

Overview
Journal Pediatr Cardiol
Date 2023 Dec 28
PMID 38153546
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Turner syndrome (TS) is associated with left-sided cardiac lesions, including hypoplastic left heart syndrome (HLHS). Mortality as high as 80-90% has been reported following stage I single-ventricle palliation (S1P) in patients with TS and HLHS (TS + HLHS). The specific factors that relate to poor outcomes are not well understood.

Methods: This is a single-center, retrospective cohort study that includes 197 patients with HLHS who underwent S1P between 2008 and 2022. The clinical outcomes and interstage hemodynamics of TS + HLHS patients (N = 11) were compared with HLHS without TS (TS-HLHS), (N = 186).

Results: Of the 11 TS + HLHS patients, 10 underwent S1P; 4 underwent Glenn and 1 had hemodynamics considered prohibitive for Glenn; only 1 survived to Fontan palliation. Post-S1P mortality was higher in TS + HLHS (60 v 25%, p = 0.017). Following S1P, TS + HLHS had higher rates of postoperative ECMO (70 v 28%, p = 0.006), surgical necrotizing enterocolitis (20 v 3%, p = 0.007), peritoneal drain placement (70 v 31%, p = 0.012), urinary tract infection (30 v 9%, p = 0.035), and ICU readmissions (median 5 v 1, p = 0.035). Interstage hemodynamics demonstrated higher right ventricular end diastolic, (11 v 8mmHg, p = 0.033), mean pulmonary artery (20 v 13mmHg) (p = 0.002), and left atrial pressures (9 v 6mmHg, p = 0.047) in TS + HLHS.

Conclusion: High mortality rates are described in TS + HLHS patients following S1P. In our cohort, despite most surviving more than 30 days post-S1P, long-term survival remained poor. Interstage catheterization data suggest poor physiologic candidacy for subsequent stages of single-ventricle palliation. Understanding the clinical and hemodynamic factors related to poor outcomes in TS + HLHS will help inform management for this population.

References
1.
Silberbach M, Roos-Hesselink J, Andersen N, Braverman A, Brown N, Collins R . Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2018; 11(10):e000048. DOI: 10.1161/HCG.0000000000000048. View

2.
Natowicz M, Kelley R . Association of Turner syndrome with hypoplastic left-heart syndrome. Am J Dis Child. 1987; 141(2):218-20. DOI: 10.1001/archpedi.1987.04460020108041. View

3.
Sybert V . Cardiovascular malformations and complications in Turner syndrome. Pediatrics. 1998; 101(1):E11. DOI: 10.1542/peds.101.1.e11. View

4.
Madriago E, Nguyen T, McFerson M, Larson E, Airhart N, Moller J . Frequency and outcomes of cardiac operations and catheter interventions in Turner syndrome. Am J Cardiol. 2012; 110(4):580-5. DOI: 10.1016/j.amjcard.2012.04.036. View

5.
van Egmond H, Orye E, Praet M, Coppens M . Hypoplastic left heart syndrome and 45X karyotype. Br Heart J. 1988; 60(1):69-71. PMC: 1216517. DOI: 10.1136/hrt.60.1.69. View